Anna Katrin Szardenings

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Siemens Medical Solutions USA, Inc., Kyorin Pharmaceutical Co., Ltd., Eli Lilly and Company. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Katrin Szardenings. Retrieved from https://idiyas.com/inventor/anna-katrin-szardenings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 64.7

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 8.1

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

San Diego, CA (US) (2008 - 2013)
Torrance, CA (US) (2011 - 2021)

Company Filing History:

7 out of 2,143

Siemens Medical Solutions USA, Inc.

patents

4 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

2 out of 4,514

Eli Lilly and Company

Activx Biosciences, Inc.

patents

6. 1 out of 2,198

Smithkline Beecham Corporation

patents

Years Active: 2008-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583887 - PSMA imaging agents (2026-03-24),

2. 12559521 - PSMA imaging agents (2026-02-24),

3. 12139554 - PSMA imaging agents (2024-11-12),

4. 12122851 - PSMA imaging agents (2024-10-22),

5. 10894807 - PSMA imaging agents (2021-01-19),

6. 10011632 - PSMA imaging agents (2018-07-03),

7. 9023318 - Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof (2015-05-05),

8. 8901112 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2014-12-02),

9. 8691187 - Imaging agents for detecting neurological disorders (2014-04-08),

10. 8541579 - Substituted diketopiperazines as oxytocin antagonists (2013-09-24),

11. 8491869 - Imaging agents for detecting neurological disorders (2013-07-23),

12. 8476261 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2013-07-02),

13. 8389514 - Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors (2013-03-05),

14. 8367673 - Substituted diketopiperazines as oxytocin antagonists (2013-02-05),

15. 8063221 - Aminoquinolones as GSK-3 inhibitors (2011-11-22),

Title: Innovations by Anna Katrin Szardenings

Introduction

Anna Katrin Szardenings is a prominent inventor based in Torrance, California. She has made significant contributions to the field of medical imaging, particularly in the development of imaging agents for prostate-specific membrane antigen (PSMA). With a total of 15 patents to her name, her work has advanced the capabilities of imaging technologies.

Latest Patents

Among her latest patents, Anna has developed PSMA imaging agents that include compounds for targeting and agents for imaging. These innovations disclose methods for synthesizing compounds and imaging agents, as well as techniques for imaging PSMA. The imaging agents she has developed are suitable for both PET and SPECT imaging, showcasing her expertise in this critical area of medical technology.

Career Highlights

Throughout her career, Anna has worked with notable companies such as Siemens Medical Solutions USA, Inc. and Kyorin Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in medical imaging.

Collaborations

Anna has collaborated with esteemed colleagues, including Umesh B Gangadharmath and Joseph C Walsh. These partnerships have further enriched her work and expanded the impact of her innovations.

Conclusion

Anna Katrin Szardenings is a trailblazer in the field of medical imaging, with a strong portfolio of patents that reflect her dedication and expertise. Her contributions continue to influence the development of advanced imaging technologies.

Profile summary based on public USPTO records.